ChromaDex (CDXC) shares results from new breakthrough study

ChromaDex (CDXC) shares results from new breakthrough study analyzing safety of high-dose nicotinamide riboside

ChromaDex (CDXC) shares results from new breakthrough study analyzing safety of high-dose nicotinamide riboside

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Haukeland , Hordaland , Norway , Charalampos Tzoulis , Translational Research In Parkinson , Sysmed Research Center , Nature Communications , Chromadex Corp , Haukeland University Hospital , Nasdaq , Kg Jebsen Center , Chromadex External Research Program , University Of Bergen , Nicotinamide Adenine Dinucleotide , Cell Metabolism , Rob Fried , Translational Research , Neuro Sysmed Research Center ,